Question 2 • CMS 2026-2027 Biology CREDIT RECOVERY
Monoclonal antibodies are produced using cell technology and can be designed to recognize specific markers on cancer cells. This lets treatments target those cells more precisely. The other choices are not typically made into targeted cancer therapies in this way.
AI-written and checked against the verified answer.